Palisade Bio Files 8-K Report
Ticker: PALI · Form: 8-K · Filed: Apr 10, 2024 · CIK: 1357459
| Field | Detail |
|---|---|
| Company | Palisade Bio, Inc. (PALI) |
| Form Type | 8-K |
| Filed Date | Apr 10, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-events, financials, filing
Related Tickers: PALI
TL;DR
Palisade Bio (PALI) filed an 8-K on 4/10. Check it for corporate updates.
AI Summary
On April 10, 2024, Palisade Bio, Inc. filed an 8-K report detailing other events and financial statements. The company, formerly known as Seneca Biopharma, Inc. and Neuralstem, Inc., is incorporated in Delaware and headquartered in Carlsbad, California.
Why It Matters
This filing provides an update on the company's corporate events and financial status, which is crucial for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for corporate events and financial statements, not indicating any immediate significant risks.
Key Players & Entities
- PALISADE BIO, INC. (company) — Registrant
- April 10, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Carlsbad, California (location) — Principal Executive Offices
- Seneca Biopharma, Inc. (company) — Former Company Name
- Neuralstem, Inc. (company) — Former Company Name
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' as of April 10, 2024.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on April 10, 2024.
What is the exact name of the company filing this report?
The exact name of the company is PALISADE BIO, INC.
In which state is Palisade Bio, Inc. incorporated?
Palisade Bio, Inc. is incorporated in Delaware.
What are the former names of Palisade Bio, Inc. mentioned in the filing?
The filing mentions that Palisade Bio, Inc. was formerly known as Seneca Biopharma, Inc. and prior to that, Neuralstem, Inc.
Filing Stats: 897 words · 4 min read · ~3 pages · Grade level 13.4 · Accepted 2024-04-10 17:29:22
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share PALI Nasdaq Capital Mark
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex99-01.htm (EX-99.1) — 15KB
- ex99-02.htm (EX-99.2) — 20KB
- ex99-01_001.jpg (GRAPHIC) — 2KB
- ex99-02_001.jpg (GRAPHIC) — 489KB
- ex99-02_002.jpg (GRAPHIC) — 600KB
- ex99-02_003.jpg (GRAPHIC) — 432KB
- ex99-02_004.jpg (GRAPHIC) — 372KB
- ex99-02_005.jpg (GRAPHIC) — 234KB
- ex99-02_006.jpg (GRAPHIC) — 241KB
- ex99-02_007.jpg (GRAPHIC) — 234KB
- ex99-02_008.jpg (GRAPHIC) — 242KB
- ex99-02_009.jpg (GRAPHIC) — 315KB
- ex99-02_010.jpg (GRAPHIC) — 234KB
- ex99-02_011.jpg (GRAPHIC) — 426KB
- ex99-02_012.jpg (GRAPHIC) — 304KB
- ex99-02_013.jpg (GRAPHIC) — 261KB
- ex99-02_014.jpg (GRAPHIC) — 316KB
- ex99-02_015.jpg (GRAPHIC) — 272KB
- ex99-02_016.jpg (GRAPHIC) — 462KB
- ex99-02_017.jpg (GRAPHIC) — 245KB
- ex99-02_018.jpg (GRAPHIC) — 210KB
- ex99-02_019.jpg (GRAPHIC) — 373KB
- ex99-02_020.jpg (GRAPHIC) — 211KB
- ex99-02_021.jpg (GRAPHIC) — 399KB
- ex99-02_022.jpg (GRAPHIC) — 311KB
- ex99-02_023.jpg (GRAPHIC) — 323KB
- ex99-02_024.jpg (GRAPHIC) — 288KB
- ex99-02_025.jpg (GRAPHIC) — 289KB
- ex99-02_026.jpg (GRAPHIC) — 231KB
- ex99-02_027.jpg (GRAPHIC) — 208KB
- 0001493152-24-014253.txt ( ) — 11995KB
- pali-20240410.xsd (EX-101.SCH) — 3KB
- pali-20240410_lab.xml (EX-101.LAB) — 33KB
- pali-20240410_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 10, 2024 Palisade Bio, Inc. /s/ J.D. Finley By: J.D. Finley Chief Executive Officer